Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Crescent Biopharma, Inc. (CBIO) had Weighted-Average Shares Outstanding (Diluted) of 0.64M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-37.88M |
|
-- |
|
-- |
|
$40.04M |
|
$-40.04M |
|
$2.16M |
|
$-37.88M |
|
$-39.10M |
|
$-37.88M |
|
$-37.88M |
|
$-37.88M |
|
$-39.10M |
|
$-40.04M |
|
$-40.00M |
|
0.64M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
0.64M |
$-59.00 |
|
$-59.00 |
|
| Balance Sheet Financials | |
$11.09M |
|
-- |
|
-- |
|
$11.09M |
|
$5.78M |
|
-- |
|
-- |
|
$5.78M |
|
$5.31M |
|
$5.31M |
|
$5.31M |
|
0.64M |
|
| Cash Flow Statement Financials | |
$-31.10M |
|
$0.02M |
|
$0.01M |
|
$41.79M |
|
$10.72M |
|
$-31.07M |
|
$4.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-31.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-712.88% |
|
-712.88% |
|
-341.52% |
|
-712.88% |
|
$8.24 |
|
$-48.20 |
|
$-48.23 |
|